News

A new study from the UK Medical Cannabis Registry found that medical cannabis may significantly improve sleep quality, reduce anxiety, and enhance quality of life in patients with insomnia. Treatment was generally well tolerated, with most side effects reported as mild or moderate.

CROWNZ took part in Cannabis Europa London 2025 — Europe’s leading conference on cannabis policy, science and innovation. We joined industry leaders to explore the future of medical cannabis and its role in transforming healthcare.

CROWNZ at Clinical Pharmacy Congress London 2025 We were proud to represent CROWNZ at CPC London 2025, the UK’s largest event for pharmacy professionals.